102
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Classifiers for Predicting Coronary Artery Disease Based on Gene Expression Profiles in Peripheral Blood Mononuclear Cells

, , , , &
Pages 5651-5663 | Published online: 15 Sep 2021

References

  • Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146–e603.
  • Ades PA, Gaalema DE. Coronary heart disease as a case study in prevention: potential role of incentives. Prev Med. 2012;55(Suppl):S75–79.
  • Mallika V, Goswami B, Rajappa M. Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective. Angiology. 2007;58(5):513–522.
  • Murabito JM, Evans JC, Larson MG, Levy D. Prognosis after the onset of coronary heart disease. An investigation of differences in outcome between the sexes according to initial coronary disease presentation. Circulation. 1993;88(6):2548–2555.
  • Malakar AK, Choudhury D, Halder B, Paul P, Uddin A, Chakraborty S. A review on coronary artery disease, its risk factors, and therapeutics. J Cell Physiol. 2019;234(10):16812–16823.
  • Trujillo TC, Dobesh PP. Traditional management of chronic stable angina. Pharmacotherapy. 2007;27(12):1677–1692.
  • McCullough PA. Coronary artery disease. Clin J Am Soc Nephrol. 2007;2(3):611–616.
  • Vernon ST, Hansen T, Kott KA, Yang JY, O’Sullivan JF, Figtree GA. Utilizing state-of-The-art “omics” technology and bioinformatics to identify new biological mechanisms and biomarkers for coronary artery disease. Microcirculation. 2019;26(2):e12488.
  • Guerreiro S, Ferreira AM, Abecasis J, et al. Additional cardiac investigation prior to the introduction of the CAD-RADS classification in coronary computed tomography angiography reports. Rev Port Cardiol. 2019;38(1):45–50.
  • Nghiem L, Potgieter C. Simulation-selection-extrapolation: estimation in high-dimensional errors-in-variables models. Biometrics. 2019;75(4):1133–1144.
  • Rigatti SJ. Random Forest. J Insur Med. 2017;47(1):31–39.
  • Sun Z, Fu X, Zhang L, Yang X, Liu F, Hu G. A protein chip system for parallel analysis of multi-tumor markers and its application in cancer detection. Anticancer Res. 2004;24(2C):1159–1165.
  • Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14:7.
  • McEligot AJ, Poynor V, Sharma R, Panangadan A. Logistic LASSO regression for dietary intakes and breast cancer. Nutrients. 2020;12:9.
  • Nedaie A, Najafi AA. Support vector machine with Dirichlet feature mapping. Neural Netw. 2018;98:87–101.
  • Noble WS. What is a support vector machine?. Nat Biotechnol. 2006;24(12):1565–1567.
  • Mehta A, Liu C, Nayak A, et al. Untargeted high-resolution plasma metabolomic profiling predicts outcomes in patients with coronary artery disease. PLoS One. 2020;15(8):e0237579.
  • Velusamy D, Ramasamy K. Ensemble of heterogeneous classifiers for diagnosis and prediction of coronary artery disease with reduced feature subset. Comput Methods Programs Biomed. 2021;198:105770.
  • Jang JJ, Bhapkar M, Coles A, et al. Predictive model for high-risk coronary artery disease. Circ Cardiovasc Imaging. 2019;12(2):e007940.
  • Vallee A, Cinaud A, Blachier V, Lelong H, Safar ME, Blacher J. Coronary heart disease diagnosis by artificial neural networks including aortic pulse wave velocity index and clinical parameters. J Hypertens. 2019;37(8):1682–1688.
  • Li L, Wang L, Li H, et al. Characterization of LncRNA expression profile and identification of novel LncRNA biomarkers to diagnose coronary artery disease. Atherosclerosis. 2018;275:359–367.
  • Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets–update. Nucleic Acids Res. 2013;41(Database issue):D991–995.
  • Law CW, Chen Y, Shi W, Smyth GK. voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 2014;15(2):R29.
  • Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.
  • Ho AM, Cabello-Arreola A, Markota M, et al. Label-free proteomics differences in the dorsolateral prefrontal cortex between bipolar disorder patients with and without psychosis. J Affect Disord. 2020;270:165–173.
  • Yu G, Wang LG, Han Y, He QY. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287.
  • Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP. GSEA-P: a desktop application for gene set enrichment analysis. Bioinformatics. 2007;23(23):3251–3253.
  • Liberzon A, Birger C, Thorvaldsdottir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417–425.
  • Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504.
  • Bindea G, Mlecnik B, Hackl H, et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009;25(8):1091–1093.
  • Engebretsen S, Bohlin J. Statistical predictions with glmnet. Clin Epigenetics. 2019;11(1):123.
  • Yong S, Jianyu M, Zhengyu W, Peng Z, Lingfeng N. Feature selection with $\ell_{2,1-2}$ regularization. IEEE Trans Neural Netw Learn Syst. 2018;29(10):4967–4982.
  • Ferreira JA. The Benjamini-Hochberg method in the case of discrete test statistics. Int J Biostat. 2007;3(1):Article 11.
  • Jiang H, Gu J, Du J, Qi X, Qian C, Fei B. A 21-gene support vector machine classifier and a 10-gene risk score system constructed for patients with gastric cancer. Mol Med Rep. 2020;21(1):347–359.
  • Huang S, Cai N, Pacheco PP, Narrandes S, Wang Y, Xu W. Applications of Support Vector Machine (SVM) learning in cancer genomics. Cancer Genomics Proteomics. 2018;15(1):41–51.
  • Su X, Xu Y, Tan Z, et al. Prediction for cardiovascular diseases based on laboratory data: an analysis of random forest model. J Clin Lab Anal. 2020;34(9):e23421.
  • Xiao Y, Hsiao TH, Suresh U, et al. A novel significance score for gene selection and ranking. Bioinformatics. 2014;30(6):801–807.
  • Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 2011;12:77.
  • Corona RI, Sudarshan S, Aluru S, Guo JT. An SVM-based method for assessment of transcription factor-DNA complex models. BMC Bioinform. 2018;19(Suppl 20):506.
  • Mack M, Gopal A. Epidemiology, traditional and novel risk factors in coronary artery disease. Heart Fail Clin. 2016;12(1):1–10.
  • Cui C, Merritt R, Fu L, Pan Z. Targeting calcium signaling in cancer therapy. Acta Pharm Sin B. 2017;7(1):3–17.
  • Lauss M, Kriegner A, Vierlinger K, Noehammer C. Characterization of the drugged human genome. Pharmacogenomics. 2007;8(8):1063–1073.
  • Wang C, Song C, Liu Q, et al. Gene expression analysis suggests immunological changes of peripheral blood monocytes in the progression of patients with coronary artery disease. Front Genet. 2021;12:641117.
  • Miao L, Yin RX, Zhang QH, et al. Integrated DNA methylation and gene expression analysis in the pathogenesis of coronary artery disease. Aging. 2019;11(5):1486–1500.
  • Chen B, Xie F, Tang C, Ma G, Wei L, Chen Z. Study of five pubertal transition-related gene polymorphisms as risk factors for premature coronary artery disease in a Chinese Han population. PLoS One. 2015;10(8):e0136496.
  • Yao J, Zhao Q, Yuan Y, et al. Identification of common prognostic gene expression signatures with biological meanings from microarray gene expression datasets. PLoS One. 2012;7(9):e45894.